ONCY
Oncolytics Biotech Inc
NASDAQ: ONCY · HEALTHCARE · BIOTECHNOLOGY
$0.88
+1.03% today
Updated 2026-04-30
Market cap
$112.49M
P/E ratio
—
P/S ratio
58.60x
EPS (TTM)
$-0.30
Dividend yield
—
52W range
$0 – $2
Volume
1.1M
Oncolytics Biotech Inc (ONCY) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-12.16M | $-13.57M | $-15.29M | $-16.82M | $-18.03M | $-22.54M | $-34.26M | $-24.44M | $-19.68M | $-15.03M | $-12.48M | $-14.89M | $-11.92M | $-19.91M | $-22.07M | $-22.43M | $-23.36M | $-28.45M | $-26.97M | $-20.11M |
| Capital expenditures | $35836.00 | $944719.00 | $111577.00 | $9763.00 | $133527.00 | $257790.00 | $126412.00 | $254834.00 | $152750.00 | $108268.00 | $23527.00 | $105765.00 | $107466.00 | $10905.00 | $29305.00 | $285948.00 | $55000.00 | $8000.00 | $239000.00 | $6000.00 |
| Depreciation | $926681.00 | $1.00M | $410254.00 | $257251.00 | $63156.00 | $92590.00 | $109275.00 | $131623.00 | $163501.00 | $180411.00 | $162233.00 | $90768.00 | $95375.00 | $485574.00 | $446187.00 | $452065.00 | $392000.00 | $403000.00 | $424000.00 | — |
| Stock-based comp | — | — | $64039.00 | $444256.00 | $3.25M | $1.81M | $730751.00 | $424384.00 | $980325.00 | $429537.00 | $406078.00 | $578703.00 | $1.42M | $1.47M | $2.56M | $3.83M | $2.38M | $2.07M | $2.72M | $3.10M |
| Free cash flow | $-12.19M | $-14.51M | $-15.40M | $-16.83M | $-18.17M | $-22.80M | $-34.38M | $-24.70M | $-19.83M | $-15.14M | $-12.50M | $-15.00M | $-12.03M | $-19.92M | $-22.10M | $-22.72M | $-23.41M | $-28.46M | $-27.20M | $-20.12M |
| Investing cash flow | $11.89M | $4.68M | $12.54M | $4.35M | $-2.06M | $1.41M | $-158853.00 | $-287250.00 | $-182791.00 | $-137560.00 | $-51350.00 | $1.98M | $-107466.00 | $-10905.00 | $-29305.00 | $-285948.00 | $-20.40M | $20.22M | $-239000.00 | — |
| Financing cash flow | $241400.00 | $12.11M | $3.46M | $38.80M | $27.29M | $14.82M | $20.85M | $30.40M | $9.04M | $23.67M | $956133.00 | $12.81M | $13.30M | $21.02M | $39.77M | $33.02M | $12.21M | $31.99M | $6.64M | — |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |